Global Veterinary Vaccines Market Size study, By Type (Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines), By Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines), and Regional Forecasts 2022-2028
Global Veterinary Vaccines Market is valued at approximately USD 8.58 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2022-2028. Veterinary vaccines play a very significant role in protecting animal health and boosting their immune system. These vaccines are parenteral products that are adopted to evade the chances of infectious diseases and multiple life-threatening disorders which is being caused by different causing agents. The growth in the companion animal population, the increasing prevalence of zoonotic diseases, coupled with the rising initiatives by various government agencies and animal associations for animal safety are the several major factors bolstering the market demand across the globe. For instance, according to The Human Society, in the United States, the number of households with a pet is estimated to be around 74.4 million (59% of households in the US) in 2018 and the amount is likely to rise and reach 90.5 million by 2022 with around 70% of overall households. Consequentially, the increasing companion animal population is fostering the demand for veterinary vaccines, which, in turn, augments the market growth in the approaching years. However, the high storage cost of vaccines and inadequate surveillance and reporting systems impede the growth of the market over the forecast period of 2022-2028. Also, rising technological developments and surging demand for advanced and competent immunization products are anticipated to act as catalyzing factors for the market demand during the forecast period.
The key regions considered for the global Veterinary Vaccines Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing demand for better animal immunization and increasing pet ownership in regions such as the US, Canada, and many other countries. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing awareness for preventive animal healthcare, as well as the rising prevalence of zoonotic diseases, would create lucrative growth prospects for the Veterinary Vaccines Market across the Asia-Pacific region.
Major market players included in this report are:
Zoetis
Merck Animal Health
Elanco
Ceva
Virbac
Vetoquinol
Phibro Animal Health
Hester Biosciences
Endovac Animal Health
Brilliant Bio Pharma Private Limited
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Porcine Vaccines
Poultry Vaccine
Livestock Vaccine
Companion Animal Vaccine
Aquaculture Vaccines
Other Animal Vaccines
By Disease:
Swine Pneumonia
Avian Influenza
Rabies
Coccidiosis
Brucellosis
Canine Distemper
By Technology:
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Veterinary Vaccines Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Companies Mentioned
Zoetis
Merck Animal Health
Elanco
Ceva
Virbac
Vetoquinol
Phibro Animal Health
Hester Biosciences
Endovac Animal Health
Brilliant Bio Pharma Private Limited
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook